eMaint Artikel
Calibration records and audit trails: What inspectors expect to see
Wondering how to manage calibration records for audit preparedness? In this article, we'll explore calibration records requirements for processes, documentation, training, and more, along with [...]
CMMS + CSV: What life sciences teams need to validate
Many industries, such as the life sciences, must meet strict regulatory requirements for facility management, equipment validation, and product safety. But that's only part of [...]
Validation drift: How equipment slowly falls out of a validated state
Imagine this scenario: A packaging line at a pharmaceutical manufacturer passed performance qualification (PQ) two years ago, and it hasn’t failed a single run since. [...]
Maintenance metrics: 5 core KPIs to track in 2026
For businesses that rely on industrial machinery, tracking maintenance metrics is essential to run lean and stay competitive. These data points give teams insights into [...]
Blog Series: Women in Reliability at Xcelerate Pt. 2
Part 2: What We Heard — Key Takeaways from the Women in Reliability Panel Xcelerate 2026 brought together maintenance and reliability professionals from across [...]
The maintenance risks behind cosmetic product recalls
The average consumer uses between six and twelve cosmetic products per day, but these products aren’t as heavily regulated by the Food and Drug [...]
The field asset visibility gap
What’s the best way to detect early warning signs of asset failure? Field asset visibility. With real-time, comprehensive performance data, you can prioritize maintenance tasks [...]
Common FDA audit findings related to equipment maintenance
For organizations in the life sciences, equipment maintenance plays a critical role in ensuring that products are pure, effective, and safe. When assets aren’t correctly [...]
Change control and equipment maintenance: The compliance risk teams miss
The pharmaceutical industry is rapidly transforming with the adoption of digital technologies and new, IoT-driven approaches like continuous manufacturing. As organizations pivot to new solutions [...]
The maintenance blind spots that delay clinical trial timelines
Developing a new pharmaceutical drug takes years of research and testing, so when it’s time to move a product to clinical trial, investors are understandably [...]